2023
DOI: 10.1101/2023.03.27.23287816
|View full text |Cite
Preprint
|
Sign up to set email alerts
|

Prevalence and risk factors of adverse effects after the first COVID-19 booster dose: evidence from Greece

Abstract: Background: In general, COVID-19 vaccines are safe and effective, but minor adverse effects are common. Objective: To estimate the prevalence of adverse effects after the first COVID-19 booster dose, and to identify possible risk factors. Material and methods: We conducted a cross-sectional study with a convenience sample in Greece during November 2022. We measured several adverse effects after the booster dose, such as pain at the injection site, swelling at the injection site, fatigue, muscle pain, headaches… Show more

Help me understand this report
View published versions

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

0
0
0

Publication Types

Select...

Relationship

0
0

Authors

Journals

citations
Cited by 0 publications
references
References 43 publications
(71 reference statements)
0
0
0
Order By: Relevance

No citations

Set email alert for when this publication receives citations?